Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
18.01
-4.73 (-20.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
Upstream Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Upstream Bio stock have an average target of 56.5, with a low estimate of 38 and a high estimate of 75. The average target predicts an increase of 213.71% from the current stock price of 18.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Upstream Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 |
---|---|
Strong Buy | 1 |
Buy | 3 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +110.99% | Nov 5, 2024 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 5, 2024 |
Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +316.44% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.